From: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
Parameter | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95.0% CI | p | Hazard ratio | 95.0% CI | p | |
Age (year) | 1.216 | 0.551–2.687 | 0.628 |  |  |  |
Clinical stage | 23.370 | 0.064–8597.978 | 0.296 |  |  |  |
Tumor scale | 1.000 | 0.454–2.202 | 0.999 |  |  |  |
Histological grade | 0.832 | 0.395–1.929 | 0.668 |  |  |  |
ER | 0.548 | 0.254–1.185 | 0.126 |  |  |  |
PR | 0.439 | 0.201–0.958 | 0.039 | 0.554 | 0.249–1.232 | 0.147 |
HER2 | 1.553 | 0.717–3.361 | 0.264 |  |  |  |
Lymph metastasis | 0.989 | 0.441–2.221 | 0.979 |  |  |  |
NAP1L1 expression | 3.851 | 1.754–8.455 | 0.001 | 3.381 | 1.512–7.559 | 0.003 |